We are live on ! Find out more
ELI

ELITE PHARMACEUTICAL
ELI

Delisted

ELI was delisted on the 20th of May, 2009.

Back to rankings

2 hedge funds and large institutions have $18.3K invested in ELITE PHARMACEUTICAL in 2013 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ELI Hedge Fund Activity: Q2 2013 in Review

2 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in ELITE PHARMACEUTICAL (ELI) for Q2 2013, worth a combined $18.3K.

Buyers outnumbered sellers: 2 funds opened new ELI positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held ELITE PHARMACEUTICAL (ELI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $18.3K of ELITE PHARMACEUTICAL stock for Q2 2013.
  • 2 funds opened new ELITE PHARMACEUTICAL positions in Q2 2013 and 0 closed out, a net change of +2 holders.

Based on aggregated 13F filings for Q2 2013.